FDA Approves New Kind of Drug for Schizophrenia
FRIDAY, Sept. 27, 2024 (HealthDay News) -- The first new type of medication in decades to help fight against schizophrenia ...
Alembic Pharma secures FDA approval for Schizophrenia treatment, stocks in red
Alembic Pharmaceuticals receives FDA approval for Paliperidone Tablets, trading at ₹1,179.95 on NSE, expanding its global ...
Bristol-Myers wins FDA nod for first-of-its-kind antipsychotic
The U.S. Food and Drug Administration (FDA) on Thursday approved Cobenfy (xanomeline and trospium chloride), developed by ...
What drinking 3 cups of coffee daily did to a study group of more than 170,000 people
Drinking too much coffee has a reputation of being harmful, but a new study says having three cups a day can lower the risk of developing more than one cardiometabolic disease.
Graphic53m
President Akufo-Addo appoints Kwame Dei Asamoah-Okyere as NBA Chief Executive
President Akufo-Addo has appointed the Director of Business Development and International Partnerships at the Food and Drugs Authority (FDA), Mr. Kwame Dei Asamoah-Okyere, as the Chief Executive ...
Investor's Business Daily on MSN35m
Bristol-Myers Squibb's Novel Schizophrenia Drug Wins FDA Approval; BMY Stock Signals Breakout
Bristol-Myers Squibb won Food and Drug Administration approval late Thursday for its novel schizophrenia drug, Cobenfy. BMY ...
SeQuent Scientific and Viyash Lifesciences announce strategic merger
The combined entity will have a stronger financial profile, enhanced R&D capabilities, and a streamlined supply chain, allowing it to serve global pharmaceutical clients more effectively ...